Letter to the Editor: Comment on "HepatoScore-14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma Risk"
- PMID: 33169424
- DOI: 10.1002/hep.31621
Letter to the Editor: Comment on "HepatoScore-14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma Risk"
Comment in
-
REPLY.Hepatology. 2021 Jun;73(6):2614. doi: 10.1002/hep.31619. Epub 2021 May 24. Hepatology. 2021. PMID: 33171542 No abstract available.
Comment on
-
HepatoScore-14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma Risk.Hepatology. 2021 Jun;73(6):2278-2292. doi: 10.1002/hep.31555. Epub 2021 Jun 15. Hepatology. 2021. PMID: 32931023 Free PMC article.
References
-
- Morris JS, Hassan MM, Zohner YE, Wang Z, Xiao L, Rashid A, et al. HepatoScore-14: measures of biological heterogeneity significantly improve prediction of hepatocellular carcinoma risk. Hepatology 2020 Sep 15. https://doi.org/10.1002/hep.31555. [Epub ahead of print]
-
- Llovet J, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999;19:329-338.
-
- Abou-Alfa GK, Pawlik TM, Shindoh J, Vauthey JN. Liver. In: Amin MB, ed. AJCC Cancer Staging Manual. 8th ed. Chicago: AJCC; 2017:287.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
